COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Maciej Banach; Maria Corina Serban; Amirhossein Sahebkar; Héctor M. García‐García; Dimitri P. Mikhailidis; Seth S. Martin; Brie Daniel; Jacek Rysz; Péter Tóth; Steven Jones; Rani K. Hasan; Svetlana Moşteoru; Mahmoud Al Rifai; Michael Pencina; Patrick W. Serruys

doi:10.1016/s0735-1097(16)30058-4

Shared by

Patrick W. Serruys

Imperial College London

COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Journal of the American College of Cardiology 67(13): 57-57

Article 2016 English

Authors

MB
Maciej Banach
MS
Maria Corina Serban
AS
Amirhossein Sahebkar

Abstract

1 min read

No abstract is provided for this article.

Related publications

Article2020

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Yoshinobu Onuma, Bernard Chevalier, Masafumi Ono, Ángel Cequier, Dariusz Dudek, Michael Haude, Didier Carrié, Manel Sabaté, Stephan Windecker, Richard Rapoza, Nick E.J. West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Íñiguez, Patrick W. Serruys

EuroIntervention

Article2014

NOBORI™ biodegradable-polymer biolimus-eluting stent versus durable-polymer drug-eluting stents: A meta-analysis

Yao‐Jun Zhang, Fei Ye, Javaid Iqbal, Shengjie Dong, Christos V. Bourantas, Nai‐Liang Tian, Patrick W. Serruys, Shao-Liang Chen

International Journal of Cardiology

Article2015

TCT-15 Multislice computed tomography assessment of absorb bioresorbable vascular scaffold in comparison with metallic drug-eluting stents: data from the ABSORB Japan trial

Kengo Tanabe, Ken Kozuma, Jeffrey J. Popma, Patrick W. Serruys, Takeshi Kimura

Journal of the American College of Cardiology

Article2016

TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

Dean J. Kereiakes, Stephen G. Ellis, Runlin Gao, Takeshi Kimura, Yoshinobu Onuma, Karine Piard‐Ruster, Yunlong Zhang, Kai Koo, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Article2011

COMPARISON OF IN VIVO ECCENTRICITY AND SYMMETRY INDICES BETWEEN METALLIC STENTS AND BIORESORBABLE VASCULAR SCAFFOLDS: INSIGHTS FROM THE ABSORB AND SPIRIT TRIALS

Salvatore Brugaletta, Josep Gómez‐Lara, Roberto Diletti, Vasim Farooq, Maria Radu, Robert‐Jan van Geuns, Bernard De Bruyne, Dariuz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourn, Cécile Dorange, Dong Li, Susan Veldhof, Yoshinobu Onuma, Nico Bruining, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Abstract

Discussion(0)

Related publications

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

NOBORI™ biodegradable-polymer biolimus-eluting stent versus durable-polymer drug-eluting stents: A meta-analysis

TCT-15 Multislice computed tomography assessment of absorb bioresorbable vascular scaffold in comparison with metallic drug-eluting stents: data from the ABSORB Japan trial

TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

COMPARISON OF IN VIVO ECCENTRICITY AND SYMMETRY INDICES BETWEEN METALLIC STENTS AND BIORESORBABLE VASCULAR SCAFFOLDS: INSIGHTS FROM THE ABSORB AND SPIRIT TRIALS